Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Lisboa MP"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lisboa MP; Universidade Federal do Rio Grande do Sul (UFRGS), Departamento de Genética, Instituto de Biociências, Programa de Pós-Graduação em Genética e Biologia Molecular, Porto Alegre, RS, Brazil., Canal D; Universidade Federal do Rio Grande do Sul (UFRGS), Departamento de Genética, Instituto de Biociências, Programa de Pós-Graduação em Genética e Biologia Molecular, Porto Alegre, RS, Brazil., Filgueiras JPC; Universidade Federal do Rio Grande do Sul (UFRGS), Departamento de Genética, Instituto de Biociências, Programa de Pós-Graduação em Genética e Biologia Molecular, Porto Alegre, RS, Brazil., Turchetto-Zolet AC; Universidade Federal do Rio Grande do Sul (UFRGS), Departamento de Genética, Instituto de Biociências, Programa de Pós-Graduação em Genética e Biologia Molecular, Porto Alegre, RS, Brazil.
Publikováno v:
Genetics and molecular biology [Genet Mol Biol] 2022 Dec 19; Vol. 45 (4), pp. e20210411. Date of Electronic Publication: 2022 Dec 19 (Print Publication: 2022).
Autor:
Naini A; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Bartetzko MP; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Sanapala SR; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Broecker F; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Wirtz V; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Lisboa MP; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Parameswarappa SG; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Knopp D; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Przygodda J; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Hakelberg M; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Pan R; Pfizer Vaccine Research and Development, Pearl River, New York 10965, United States., Patel A; Pfizer Vaccine Research and Development, Pearl River, New York 10965, United States., Chorro L; Pfizer Vaccine Research and Development, Pearl River, New York 10965, United States., Illenberger A; Pfizer Vaccine Research and Development, Pearl River, New York 10965, United States., Ponce C; Pfizer Vaccine Research and Development, Pearl River, New York 10965, United States., Kodali S; Pfizer Vaccine Research and Development, Pearl River, New York 10965, United States., Lypowy J; Pfizer Vaccine Research and Development, Pearl River, New York 10965, United States., Anderson AS; Pfizer Vaccine Research and Development, Pearl River, New York 10965, United States., Donald RGK; Pfizer Vaccine Research and Development, Pearl River, New York 10965, United States., von Bonin A; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany., Pereira CL; Vaxxilon Deutschland GmbH, Part of Idorsia Pharmaceuticals Ltd., Magnusstr. 11, 12489 Berlin, Germany.
Publikováno v:
JACS Au [JACS Au] 2022 Aug 31; Vol. 2 (9), pp. 2135-2151. Date of Electronic Publication: 2022 Aug 31 (Print Publication: 2022).
Autor:
Kaplonek P; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany.; Institute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany., Khan N; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany., Reppe K; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany., Schumann B; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany., Emmadi M; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany., Lisboa MP; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany., Xu FF; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany., Calow ADJ; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany., Parameswarappa SG; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany., Witzenrath M; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 10117 Berlin, Germany., Pereira CL; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany., Seeberger PH; Department of Biomolecular Systems, Max-Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany; peter.seeberger@mpikg.mpg.de.; Institute of Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Dec 26; Vol. 115 (52), pp. 13353-13358. Date of Electronic Publication: 2018 Dec 07.
Autor:
Emmadi M; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , D-14424 Potsdam, Germany., Khan N; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , D-14424 Potsdam, Germany., Lykke L; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , D-14424 Potsdam, Germany., Reppe K; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin , Charitéplatz 1, 10117 Berlin, Germany., G Parameswarappa S; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , D-14424 Potsdam, Germany., Lisboa MP; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , D-14424 Potsdam, Germany., Wienhold SM; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin , Charitéplatz 1, 10117 Berlin, Germany., Witzenrath M; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin , Charitéplatz 1, 10117 Berlin, Germany., Pereira CL; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , D-14424 Potsdam, Germany., Seeberger PH; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces , D-14424 Potsdam, Germany.; Department of Chemistry and Biochemistry, Freie Universität Berlin , Arnimallee 22, D-14195 Berlin, Germany.
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 2017 Oct 18; Vol. 139 (41), pp. 14783-14791. Date of Electronic Publication: 2017 Oct 04.
Autor:
Lisboa MP; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, D-14424 Potsdam, Germany., Khan N; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, D-14424 Potsdam, Germany., Martin C; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, D-14424 Potsdam, Germany.; Department of Chemistry and Biochemistry, Freie Universität Berlin, D-14195 Berlin, Germany., Xu FF; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, D-14424 Potsdam, Germany.; Department of Chemistry and Biochemistry, Freie Universität Berlin, D-14195 Berlin, Germany., Reppe K; Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany., Geissner A; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, D-14424 Potsdam, Germany.; Department of Chemistry and Biochemistry, Freie Universität Berlin, D-14195 Berlin, Germany., Govindan S; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, D-14424 Potsdam, Germany., Witzenrath M; Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany., Pereira CL; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, D-14424 Potsdam, Germany; claney.pereira@vaxxilon.com peter.seeberger@mpikg.mpg.de., Seeberger PH; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, D-14424 Potsdam, Germany; claney.pereira@vaxxilon.com peter.seeberger@mpikg.mpg.de.; Department of Chemistry and Biochemistry, Freie Universität Berlin, D-14195 Berlin, Germany.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2017 Oct 17; Vol. 114 (42), pp. 11063-11068. Date of Electronic Publication: 2017 Oct 02.
Autor:
Schumann B; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424, Potsdam, Germany.; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195, Berlin, Germany., Parameswarappa SG; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424, Potsdam, Germany., Lisboa MP; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424, Potsdam, Germany., Kottari N; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424, Potsdam, Germany., Guidetti F; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424, Potsdam, Germany., Pereira CL; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424, Potsdam, Germany. claney.pereira@vaxxilon.com., Seeberger PH; Department of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, 14424, Potsdam, Germany. peter.seeberger@mpikg.mpg.de.; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Arnimallee 22, 14195, Berlin, Germany. peter.seeberger@mpikg.mpg.de.
Publikováno v:
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2016 Nov 07; Vol. 55 (46), pp. 14431-14434. Date of Electronic Publication: 2016 Oct 13.
Autor:
Lisboa MP; Department of Chemistry and Biochemistry, Florida State University, 95 Chieftan Way, Tallahassee FL 32306-4390 (USA), Fax: (+1) 850-644-8281., Dudley GB
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2013 Nov 25; Vol. 19 (48), pp. 16146-68. Date of Electronic Publication: 2013 Nov 04.
Autor:
Benitez LB; Laboratório de BioquÍmica e Microbiologia Aplicada, Departamento de Ciência de Alimentos, ICTA, Universidade Federal do Rio Grande do Sul, 91501-970, Porto Alegre, Brazil., Velho RV, Lisboa MP, Medina LF, Brandelli A
Publikováno v:
Journal of microbiology (Seoul, Korea) [J Microbiol] 2010 Dec; Vol. 48 (6), pp. 791-7. Date of Electronic Publication: 2011 Jan 09.